Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Automatic Recognition of Freezing of Gait Episodes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00738075
First received: August 17, 2008
Last updated: August 19, 2008
Last verified: August 2008
  Purpose

The investigators hypothesize that mathematical algorithm can identify freezing episodes based on data obtained from accelerometer.


Condition Intervention
Parkinson's Disease
Device: Auditory cue

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Online Automatic Recognition of Freezing of Gait Episodes

Resource links provided by NLM:


Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment: 30
Study Start Date: October 2008
Estimated Study Completion Date: October 2009
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
PD+FOG
Patients with Parkinson's disease prone to freezing
Device: Auditory cue
When device recognizes automatically freezing episode it will generate auditory cue

Detailed Description:

The subjects will walk with an accelerometer. The acceleration traces will be online analyzed, and if freezing episode is recognized, an auditory cue will be heard.

  Eligibility

Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with Parkinson's disease prone to freezing of gait

Criteria

Inclusion Criteria:

  • Patients with Parkinsons disease prone to freezing of gait

Exclusion Criteria:

  • Patients who are not able to ambulate independently
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00738075

Contacts
Contact: Meir Plotnik, PhD +972-3-6973960 meirp@tasmc.health.gov.il

Locations
Israel
Laboratory for Gait and Neurodynamics, Tel Aviv Sourasky Medical Center Not yet recruiting
Tel Aviv, Israel, 64239
Contact: Meir Plotnik, PhD    +972-3-6973960      
Sub-Investigator: Meir Plotnik, PhD         
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Study Director: Meir Plotnik, PhD Tel-Aviv Sourasky Medical Center
  More Information

Publications:
Responsible Party: Nir Giladi MD, Tel Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT00738075     History of Changes
Other Study ID Numbers: TASMC-08-NG-0283-CTIL
Study First Received: August 17, 2008
Last Updated: August 19, 2008
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Parkinson Disease
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders

ClinicalTrials.gov processed this record on November 27, 2014